AGRITOPE INC
10-Q, EX-27, 2000-08-14
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: AGRITOPE INC, 10-Q, 2000-08-14
Next: NEUMEIER INVESTMENT COUNSEL LLC, 13F-HR/A, 2000-08-11



<TABLE> <S> <C>

<ARTICLE>                       5
<LEGEND>
This schedule contains summary financial information extracted from the
condensed consolidated financial statements included herein and is qualified in
its entirety by reference to such financial statements.
</LEGEND>
<MULTIPLIER>                    1

<S>                                                  <C>
<PERIOD-TYPE>                                        9-MOS
<FISCAL-YEAR-END>                                    SEP-30-2000
<PERIOD-END>                                         JUN-30-2000
<CASH>                                                 1,463,343
<SECURITIES>                                                   0
<RECEIVABLES>                                          1,443,489
<ALLOWANCES>                                             (18,307)
<INVENTORY>                                            5,207,734
<CURRENT-ASSETS>                                       8,377,477
<PP&E>                                                 6,786,187
<DEPRECIATION>                                        (3,676,077)
<TOTAL-ASSETS>                                        13,402,262
<CURRENT-LIABILITIES>                                  5,017,237
<BONDS>                                                        0
                                          0
                                                7,143
<COMMON>                                                  41,307
<OTHER-SE>                                             6,634,614
<TOTAL-LIABILITY-AND-EQUITY>                          13,402,262
<SALES>                                                2,830,954
<TOTAL-REVENUES>                                       5,097,442
<CGS>                                                  2,662,856
<TOTAL-COSTS>                                          2,662,856
<OTHER-EXPENSES>                                       5,890,228
<LOSS-PROVISION>                                               0
<INTEREST-EXPENSE>                                       109,342
<INCOME-PRETAX>                                       (3,040,662)
<INCOME-TAX>                                                   0
<INCOME-CONTINUING>                                   (3,040,662)
<DISCONTINUED>                                                 0
<EXTRAORDINARY>                                                0
<CHANGES>                                                      0
<NET-INCOME>                                          (3,040,662)
<EPS-BASIC>                                                 (.74)
<EPS-DILUTED>                                               (.74)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission